RxDoctor Payments Data
★ My doctorsLook up a doctor →

Stefanie Ferraro

Psychiatric/Mental Health · Newark, DENPI 1811464100

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 110 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.

$2,195in general payments, 2019–2025

Across 110 payments — averaging $19.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$506
  • Takeda Pharmaceuticals U.S.A., Inc.$232
  • Axsome Therapeutics, Inc.$186
  • Otsuka America Pharmaceutical, Inc.$171
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$165
  • Supernus Pharmaceuticals, Inc.$161
  • plus $775 from 15 others

What the payments were for

  • Food & beverage$2,195100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie25$506
Takeda Pharmaceuticals U.S.A., Inc.10$232
Axsome Therapeutics, Inc.9$186
Otsuka America Pharmaceutical, Inc.11$171
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$165
Supernus Pharmaceuticals, Inc.8$161
Neurocrine Biosciences, Inc.6$137
Collegium Pharmaceutical, Inc.4$90
Lundbeck LLC4$80
Corium, LLC3$67
Vanda Pharmaceuticals Inc.2$60
Eisai Inc.3$59
Vertical Pharmaceuticals, LLC3$51
Bausch Health US, LLC3$41
Sage Therapeutics, LLC2$40
Tris Pharma Inc3$39
Sunovion Pharmaceuticals Inc.2$36
Alkermes, Inc.1$21
Neos Therapeutics, LP1$21
Teva Pharmaceuticals USA, Inc.1$20
Avanir Pharmaceuticals, Inc.1$12

How this compares

$2,195 in reported general payments places this provider in the 75th percentile of 177 psychiatric/mental health providers in Delaware.

See all psychiatric/mental health providers in Delaware →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Escitalopram Oxalate11$51

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Newark

See the full list for Delaware →

Where these figures come from

Is this you, or does something look wrong? →